Alveolar ridge preservation reduces the need for ancillary bone augmentation in the context of implant therapy.

Couso-Queiruga, Emilio; Mansouri, Cyrus J; Alade, Azeez A; Allareddy, Trishul V; Galindo-Moreno, Pablo; Avila-Ortiz, Gustavo (2022). Alveolar ridge preservation reduces the need for ancillary bone augmentation in the context of implant therapy. Journal of periodontology, 93(6), pp. 847-856. Wiley 10.1002/JPER.22-0030

Preview

Text Journal_of_Periodontology_-_2022_-_Couso_Queiruga_-_Alveolar_ridge_preservation_reduces_the_need_for_ancillary_bone.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (968kB) | Preview

BACKGROUND

There is limited information on the need for bone augmentation in the context of delayed implant placement whether alveolar ridge preservation (ARP) is previously performed or not. The primary aim of this retrospective cohort study was to evaluate the efficacy of ARP therapy after tooth extraction compared with unassisted socket healing (USH) in reducing the need for ancillary bone augmentation before or at the time of implant placement.

METHODS

Adult subjects that underwent non-molar single tooth extraction with or without simultaneous ARP therapy were included in this study. Cone beam computed tomography scans obtained before tooth extraction and after a variable healing period were used to record the baseline facial bone thickness and to virtually plan implant placement according to a standard method. A logistic regression model was used to evaluate the effect of facial alveolar bone thickness upon tooth extraction and baseline therapy (USH or ARP) on the need for additional bone augmentation, adjusting for several covariates (i.e., age, sex, baseline KMW, and tooth type).

RESULTS

One hundred and forty subjects that were equally distributed between both baseline therapy groups constituted the study population. Implant placement was deemed virtually feasible in all study sites. Simultaneous bone augmentation was considered necessary in 60% and 11.4% of the sites in the USH and ARP group, respectively. Most of these sites (64.2% in the USH group and 87.5% in the ARP group) exhibited a thin facial bone phenotype (<1 mm) at baseline. Logistic regression revealed that the odds of not needing ancillary bone augmentation were 17.8 times higher in sites that received ARP therapy. Furthermore, the need for additional bone augmentation was reduced 7.7 times for every 1 mm increase in facial bone thickness, regardless of baseline therapy.

CONCLUSIONS

Based on a digital analysis, ARP therapy, compared with USH, and thick facial alveolar bone largely reduce the need for ancillary bone augmentation at the time of implant placement in non-molar sites.

Interest & Impact

Downloads

16 since deposited on 21 Nov 2023
16 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item